Canada's Drug Agency has anchored its draft public-coverage recommendation for Mounjaro to the current list price of Ozempic, suggesting public plans pay no more for 5 mg tirzepatide than they pay for 1 mg semaglutide, currently listed at about $228 per four-week supply [Source: theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/]
Because it can lower overall calorie intake, tirzepatide often leads to weight loss when combined with healthy lifestyle habits
They share the same three primary receptor targets: GLP-1 GIP Glucagon Because of this shared mechanism, both compounds are part of the broader movement toward multi-agonist incretin drugs designed to influence several metabolic hormone systems simultaneously
Phase 3 trials are currently underway, with results expected in 2026-2027
lol Oral GLP-1s have been around for some time, however their efficacy is improving dramatically due to the technological advancements in #pharmaceutical #formulations
Biochim Biophys Acta - Bioenerg (2015) 1847(11):1387400